DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
DELANZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Multiple Myeloma
Unknown
DELANZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6IF28942WO
Molecule Type:
Small molecule
Molecular Formula:
C21H28BN3O5
Molecular Weight:
413.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VERDINEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VERDINEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
85Q03215IW
Molecule Type:
Small molecule
Molecular Formula:
C18H12F6N6O
Molecular Weight:
442.32
AlogP:
3.99
PSA:
84.73
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BOS161721
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
BOS161721
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INCAGN-02385
1
Unknown
Investigational
Unknown
Unknown
Melanoma
Unknown
INCAGN-02385
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0A08C63DF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
SERIDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Dopamine D2 receptor modulator
SERIDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
1359K87ZYE
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PCO-371
1
Small molecule
Investigational
Unknown
Unknown
Hypoparathyroidism
Unknown
PCO-371
×
Maximum Phase:
1
First Approval:
None
UNII:
TE53TU0WSQ
Molecule Type:
Small molecule
Molecular Formula:
C29H32F3N5O6S
Molecular Weight:
635.67
AlogP:
3.32
PSA:
137.48
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LECOZOTAN
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
LECOZOTAN
×
Maximum Phase:
1
First Approval:
None
UNII:
48854OTZ5E
Molecule Type:
Small molecule
Molecular Formula:
C28H29N5O3
Molecular Weight:
483.57
AlogP:
3.58
PSA:
81.93
HBD:
0.0
HBA:
#RotB:
6.0
Source:
SALVINORIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALVINORIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
T56W91NG6J
Molecule Type:
Small molecule
Molecular Formula:
C23H28O8
Molecular Weight:
432.47
AlogP:
3.0
PSA:
109.11
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PHA-793887
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
PHA-793887
×
Maximum Phase:
1
First Approval:
None
UNII:
MKS45S912B
Molecule Type:
Small molecule
Molecular Formula:
C19H31N5O2
Molecular Weight:
361.49
AlogP:
2.31
PSA:
81.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ALEPLASININ
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Plasminogen activator inhibitor-1 inhibitor
ALEPLASININ
×
Maximum Phase:
1
First Approval:
None
UNII:
LL56J87F3X
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3
Molecular Weight:
425.53
AlogP:
6.23
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
GAMMA-AMINOBUTYRIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Epilepsy
Unknown
GAMMA-AMINOBUTYRIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
2ACZ6IPC6I
Molecule Type:
Small molecule
Molecular Formula:
C4H9NO2
Molecular Weight:
103.12
AlogP:
-0.19
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AVL-3288
1
Small molecule
Investigational
Unknown
Unknown
Psychotic Disorders; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator
AVL-3288
×
Maximum Phase:
1
First Approval:
None
UNII:
VA80VAX4WF
Molecule Type:
Small molecule
Molecular Formula:
C19H15Cl2N3O2
Molecular Weight:
388.25
AlogP:
5.38
PSA:
67.16
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ADCT-602
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ADCT-602
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FS-102
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
FS-102
×
Maximum Phase:
1
First Approval:
None
UNII:
Z27ZI1MZY9
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALX-009
1
Unknown
Investigational
Unknown
Unknown
Bronchiectasis; Cystic Fibrosis
Unknown
ALX-009
×
Maximum Phase:
1
First Approval:
None
UNII:
2BP92KEU27
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLAZINEMDOR
1
Unknown
Investigational
Unknown
Unknown
Schizophrenia
Unknown
PLAZINEMDOR
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NZV-930
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
NZV-930
×
Maximum Phase:
1
First Approval:
None
UNII:
2M0F9Q9SZ2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANTI-PR1/HLA-A2 MONOCLONAL ANTIBODY HU8F4
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ANTI-PR1/HLA-A2 MONOCLONAL ANTIBODY HU8F4
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COM-701
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
COM-701
×
Maximum Phase:
1
First Approval:
None
UNII:
IAY02XUV7L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MDX-CD4
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MDX-CD4
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METFORMIN EICOSAPENTAENOATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
METFORMIN EICOSAPENTAENOATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BFCR4350A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
BFCR4350A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LUFOTRELVIR
1
Small molecule
Investigational
Unknown
Unknown
Virus Diseases
Unknown
LUFOTRELVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H33N4O9P
Molecular Weight:
552.52
AlogP:
1.01
PSA:
196.15
HBD:
6.0
HBA:
#RotB:
13.0
Source:
GLUCAGON-LIKE PEPTIDE 1
1
Protein
Investigational
Unknown
Unknown
Heart Failure
Unknown
GLUCAGON-LIKE PEPTIDE 1
×
Maximum Phase:
1
First Approval:
None
UNII:
SQ6SA9L9XQ
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SONTUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 other
SONTUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBENDAZIM
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Unknown
CARBENDAZIM
×
Maximum Phase:
1
First Approval:
None
UNII:
H75J14AA89
Molecule Type:
Small molecule
Molecular Formula:
C9H9N3O2
Molecular Weight:
191.19
AlogP:
1.74
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
1.0
Source:
FALNIDAMOL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
FALNIDAMOL
×
Maximum Phase:
1
First Approval:
None
UNII:
0MU316797D
Molecule Type:
Small molecule
Molecular Formula:
C18H19ClFN7
Molecular Weight:
387.85
AlogP:
3.46
PSA:
78.86
HBD:
2.0
HBA:
#RotB:
4.0
Source:
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ZAMPILIMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
ZAMPILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
52B38H09GZ
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986318
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-986318
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FELVIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Fusion glycoprotein F0 inhibitor
FELVIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HE3235
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor modulator
HE3235
×
Maximum Phase:
1
First Approval:
None
UNII:
891O182ZP5
Molecule Type:
Small molecule
Molecular Formula:
C21H32O2
Molecular Weight:
316.49
AlogP:
3.75
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
1
2
…
75
76
77
78
79
80
81
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA